In addition, COMMD2 expression was positively correlated with CD8+ T cells, macrophages, myeloid dendritic cells, and neutrophil‐infiltrated cells in numerous cancers, implying that COMMD2 had a impact on immune cell infiltration and may affect tumor immunotherapy. The gene discussed is CD8A; the disease is cancer.